We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




ALS Associated Gene Identified Using Innovative Strategy

By LabMedica International staff writers
Posted on 11 Nov 2014
Print article
Image: Micrograph of a muscle biopsy from a patient with amyotrophic lateral sclerosis demonstrating the typical \"grouped atrophy\" of muscle fibers that occurs with denervation (Photo courtesy of the University of Utah).
Image: Micrograph of a muscle biopsy from a patient with amyotrophic lateral sclerosis demonstrating the typical \"grouped atrophy\" of muscle fibers that occurs with denervation (Photo courtesy of the University of Utah).
An innovative exome sequencing strategy has been used to identify a gene that encodes for a specific protein and is associated with familial amyotrophic lateral sclerosis (ALS), a fatal neurological disorder also known as Lou Gehrig's Disease.

Exome sequencing, in contrast to whole genome sequencing, relies on sequencing only the protein-coding genes in a genome and has been an effective and cost-efficient strategy for identifying disease-causing genetic mutations.

A team of scientists led by those at University of Massachusetts Medical School (Worcester, MA, USA) performed an exome-wide screen on 363 people with familial ALS (FALS) each of whom also had a family member with the condition. The investigators went onto analyze a further 272 FALS cases and 5,510 internal controls to confirm the overrepresentation as statistically significant and replicable. An analysis of every coding gene in the genome of these patients was performed and then searched for patterns of rare, damaging mutations that appeared more frequently in patients with ALS than in the general population.

The results revealed an excess of patient variants within TUBA4A, the gene encoding the Tubulin, Alpha 4A protein. Analysis of the extra 272 FALS cases and 5,510 internal controls confirmed the overrepresentation as statistically significant and replicable. The protein TUBA4A helps build the microtubule network, one of the most important structural components of the nerve cell. The scientists found that the mutated TUBA4A protein is toxic to the neuron by weakening the entire microtubule network.

ALS is a progressive, neurodegenerative disorder affecting the motor neurons in the central nervous system. As motor neurons die, the brain's ability to send signals to the body's muscles is compromised. This leads to a loss of voluntary muscle movement, paralysis and eventually respiratory failure. The cause of most cases of ALS is not known and approximately 10% of cases are inherited.

John E. Landers, PhD, a professor of Neurology and senior author of the study said, “Every single one of us carries rare mutations which make the identification of disease-associated genes difficult. By analyzing the mutation rate of every gene in our patients and comparing them to the general population, we were able to show that the TUBA4A gene had an elevated frequency of mutation in patients.” The study was published on October 22, 2014, in the journal Neuron.

Related Links:

University of Massachusetts Medical School 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.